Kairos Pharma Ltd (AMEX:KAPA)’s traded shares stood at 1.84 million during the last session. At the close of trading, the stock’s price was $0.57, to imply an increase of 16.16% or $0.08 in intraday trading. The KAPA share’s 52-week high remains $4.00, putting it -601.75% down since that peak but still an impressive 29.82% since price per share fell to its 52-week low of $0.40. The company has a valuation of $9.60M, with an average of 3.59 million shares in intraday trading volume over the past 10 days and average of 647.36K shares over the past 3 months.
Kairos Pharma Ltd (AMEX:KAPA) trade information
After registering a 16.16% upside in the last session, Kairos Pharma Ltd (KAPA) has traded red over the past five days. The 5-day price performance for the stock is 13.43%, and -8.08% over 30 days. With these gigs, the year-to-date price performance is -62.50%. Short interest in Kairos Pharma Ltd (AMEX:KAPA) saw shorts transact 19410.0 shares and set a 0.08 days time to cover.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -23.37% for the past 5-year period. While 2025 is set for a 7.25% return in earnings, projections for the next 5 years are at -24.45% annually.
KAPA Dividends
Kairos Pharma Ltd has its next earnings report out on 2025-May-13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Kairos Pharma Ltd (AMEX:KAPA)’s Major holders
Kairos Pharma Ltd insiders hold 47.25% of total outstanding shares, with institutional holders owning 9.36% of the shares at 17.75% float percentage. In total, 9.36% institutions holds shares in the company.
We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Kairos Pharma Ltd (KAPA) shares. Going by data provided on Mar 31, 2025 , Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 16.76 shares. This is just over 0.10% of the total shares, with a market valuation of $9551.0. Data from the same date shows that the other fund manager holds a little less at 3.68, or 0.02% of the shares, all valued at about 2095.0.
